Login to Your Account

Alkermes Buying Reliant In Stock Purchase Worth $934M

By Aaron Lorenzo

Friday, March 22, 2002
Scooping up the shares it doesn’t already own, Alkermes Inc. agreed to purchase the remaining 81 percent of Reliant Pharmaceuticals LLC in a stock deal worth about $934 million. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription